173 related articles for article (PubMed ID: 38163890)
1. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding.
Lin Y; Wu Y; Zhang Q; Tu X; Chen S; Pan J; Xu N; Lin M; She P; Niu G; Chen Y; Li H
J Exp Clin Cancer Res; 2024 Jan; 43(1):1. PubMed ID: 38163890
[TBL] [Abstract][Full Text] [Related]
2. Correction: RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding.
Lin Y; Wu Y; Zhang Q; Tu X; Chen S; Pan J; Xu N; Lin M; She P; Niu G; Chen Y; Li H
J Exp Clin Cancer Res; 2024 Feb; 43(1):37. PubMed ID: 38302969
[No Abstract] [Full Text] [Related]
3. Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.
Fan RY; Wu JQ; Liu YY; Liu XY; Qian ST; Li CY; Wei P; Song Z; He MF
J Exp Clin Cancer Res; 2021 Nov; 40(1):371. PubMed ID: 34801071
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
5. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
Cancer Biomark; 2017 Dec; 21(1):221-228. PubMed ID: 29060934
[TBL] [Abstract][Full Text] [Related]
6. Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer.
Xu Y; Huang Y; Weng L; Zheng J; Huang Y; Lin Y; Zhao Y; Li H; Chen Y
J Cancer Res Clin Oncol; 2020 Jan; 146(1):273-285. PubMed ID: 31641854
[TBL] [Abstract][Full Text] [Related]
7. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and mechanism study of cordycepin against brain metastases of small cell lung cancer based on zebrafish.
Zhang SR; Pan M; Gao YB; Fan RY; Bin XN; Qian ST; Tang CL; Ying HJ; Wu JQ; He MF
Phytomedicine; 2023 Jan; 109():154613. PubMed ID: 36610112
[TBL] [Abstract][Full Text] [Related]
10. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
[TBL] [Abstract][Full Text] [Related]
11. The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.
Dai L; Smith CD; Foroozesh M; Miele L; Qin Z
Int J Cancer; 2018 May; 142(10):2153-2162. PubMed ID: 29277894
[TBL] [Abstract][Full Text] [Related]
12. Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases.
Cacho-Díaz B; Cuapantécatl LD; Garcilazo-Reyes YJ; Cabrera-Miranda L; Hernandez-Martinez JM; Arrieta O
Oncology; 2022; 100(10):542-554. PubMed ID: 35988535
[TBL] [Abstract][Full Text] [Related]
13. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis.
Chen Y; Wang M; Zhong W; Zhao J
Lung Cancer; 2013 Nov; 82(2):313-8. PubMed ID: 24011632
[TBL] [Abstract][Full Text] [Related]
15. Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer.
Sabari JK; Velcheti V; Shimizu K; Strickland MR; Heist RS; Singh M; Nayyar N; Giobbie-Hurder A; Digumarthy SR; Gainor JF; Rajan AP; Nieblas-Bedolla E; Burns AC; Hallin J; Olson P; Christensen JG; Kurz SC; Brastianos PK; Wakimoto H
Clin Cancer Res; 2022 Aug; 28(15):3318-3328. PubMed ID: 35404402
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of PD-1/L1 inhibitors in brain metastases of non-small-cell lung cancer: pooled analysis from seven randomized controlled trials.
Li W; Jiang J; Huang L; Long F
Future Oncol; 2022 Jan; 18(3):403-412. PubMed ID: 34787500
[TBL] [Abstract][Full Text] [Related]
17. Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.
Muñiz-Hernández S; Huerta-Yepez S; Hernández-Pedro N; Ramírez-Tirado LA; Aviles-Salas A; Maldonado A; Hernández-Cueto D; Baay-Guzmán G; Arrieta O
Int J Clin Oncol; 2016 Dec; 21(6):1051-1061. PubMed ID: 27306217
[TBL] [Abstract][Full Text] [Related]
18. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
Yu X; Sheng J; Pan G; Fan Y
Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
[TBL] [Abstract][Full Text] [Related]
19. Silencing of circ_0000517 suppresses proliferation, glycolysis, and glutamine decomposition of non-small cell lung cancer by modulating miR-330-5p/YY1 signal pathway.
Bing ZX; Zhang JQ; Wang GG; Wang YQ; Wang TG; Li DQ
Kaohsiung J Med Sci; 2021 Dec; 37(12):1027-1037. PubMed ID: 34405943
[TBL] [Abstract][Full Text] [Related]
20. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR
Yin W; Zhao Y; Kang X; Zhao P; Fu X; Mo X; Wang Y; Huang Y
Theranostics; 2020; 10(14):6122-6135. PubMed ID: 32483443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
